Skip to main content

Home/ History Readings/ Group items tagged biosafety

Rss Feed Group items tagged

Javier E

Opinion | The Government Must Say What It Knows About Covid's Origins - The New York Times - 0 views

  • By keeping evidence that seemed to provide ammunition to proponents of a lab leak theory under wraps and resisting disclosure, U.S. officials have contributed to making the topic of the pandemic’s origins more poisoned and open to manipulation by bad-faith actors.
  • Treating crucial information like a dark secret empowers those who viciously and unfairly accuse public health officials and scientists of profiting off the pandemic. As Megan K. Stack wrote in Times Opinion this spring, “Those who seek to suppress disinformation may be destined, themselves, to sow it.”
  • According to an Economist/YouGov poll published in March, 66 percent of Americans — including majorities of Democrats and independents — believe the pandemic was caused by research activities, a number that has gone up since 2020
  • ...5 more annotations...
  • The American public, however, only rarely heard refreshing honesty from their officials or even their scientists — and this tight-lipped, denialist approach appears to have only strengthened belief that the pandemic arose from carelessness during research or even, in less reality-based accounts, something deliberate
  • Only 16 percent of Americans believed that it was likely or definitely false that the emergence of the Covid virus was tied to research in a Chinese lab, while 17 percent were unsure.
  • Worse, biosafety, globally, remains insufficiently regulated. Making biosafety into a controversial topic makes it harder to move forward with necessary regulation and international effort
  • For years, scientists and government officials did not publicly talk much about the fact that a 1977 “Russian” influenza pandemic that killed hundreds of thousands of people most likely began when a vaccine trial went awry.
  • one reason for the relative silence was the fear of upsetting the burgeoning cooperation over flu surveillance and treatment by the United States, China and Russia.
yehbru

Opinion: Covid-19 has revealed just how vulnerable we are to biosecurity threats - CNN - 0 views

  • The field of biosecurity -- aimed at keeping nations safe from natural or human-made pathogens -- has long been eclipsed by cybersecurity and counterterrorism
  • Covid-19, which is often compared to the flu pandemic of 1918, has been called a once-in-a-generation event. But the outbreak of MERS and SARS in recent years shows just how frequent emerging diseases can occur.
  • A significant increase in biological containment facilities over the last 30 years also poses a grave risk. There are now more than 50 facilities around the world that are categorized as "Level 4" labs, which contain the deadliest pathogens and require the highest level of safety, and thousands more are designated "Level 3" facilities that contain infectious agents or toxins that may cause potentially lethal infection. While it is highly unlikely that Covid-19 emerged from a laboratory in Wuhan, the pandemic has raised the specter of a possible leak or act of bioterrorism. Containment facilities are an Achilles heel in biosecurity, and these labs, along with those who work there, should be subject to greater international scrutiny.
  • ...10 more annotations...
  • We must not ignore the threat of bad actors gaining access to these dangerous pathogens, which are the ultimate terror weapons, due to their potentially massive impact
  • In Germany, security services interdicted vast amounts of the toxin ricin, which, authorities said, a couple was planning to use in a biological attack in 2018
  • Instead of looking to weaponize a highly virulent pathogen like anthrax -- the spore-forming bacterium which was infamously mailed out to media outlets and politicians in a bio attack in 2001, killing five people and injuring 17 more -- bad actors are now likely considering the efficacy of a less virulent but highly transmissible pathogen like SARS-CoV-2, which has brought the world to its knees in the last year. This pathogen has shown that transmissibility -- rather than toxicity -- is a major factor when it comes to mass disruption.
  • When it comes to policies that are already in place, there is the Biological and Toxic Weapons Convention (BTWC), a multilateral treaty that went into effect in 1975, which prohibits the development, production, acquisition and stockpiling of biological agents and toxins and any related delivery systems that have "no justification for prophylactic, protective or other peaceful purposes."
  • However, it is poorly funded in comparison to other treaties like the Chemical Weapons Convention, and does not have a corresponding body like the Organization for the Prohibition of Chemical Weapons (OPCW) to police it.
  • The World Health Organization could also implement an early warning system to predict pandemics, showing its progress around the globe.
  • MCMs are products such as vaccines, biologics and pharmaceutical drugs that can diagnose, protect or treat the effects of a naturally occurring new disease or biological attack. In the future, it may be more cost effective to pay the pharmaceutical industry ahead of time to produce treatments and vaccines rather than wait for a pandemic to develop.
  • The pandemic has also underscored the importance of manufacturing and stockpiling medical gear including personal protective equipment to avoid logjams in the supply chain and a reliance on other countries like China for these critical supplies. Providing accurate and accessible information to the public is also key; propaganda and disinformation must not be taken lightly.
  • Going forward, we should treat biosecurity threats with the same urgency in the 21st century as world leaders approached atomic bombs in the 20th century.
  • A first step would be for the UN Security Council to fund and enforce the Biological and Toxic Weapons Convention.
ethanshilling

China's Plan to Win in a Post-Pandemic World - The New York Times - 0 views

  • China unveiled a road map for cementing its rise in a post-Covid world as it opened one of its biggest political events of the year on Friday, casting its success against the coronavirus as evidence of the superiority of its top-down leadership while warning of threats at home and abroad.
  • The message on Friday was one of optimism about the strength of its economy and the solidarity of its people, and of struggle against an array of challenges: a hostile global environment, demographic crises at home and resistance to its rule of Hong Kong.
  • According to the plan, the Basic Law, Hong Kong’s mini-Constitution, will be amended to change the process of selecting the territory’s chief executive and the legislature.
  • ...14 more annotations...
  • The changes will amount to a new electoral process with “Hong Kong characteristics,” Wang Chen, a Politburo member who specializes in legal matters, said in a speech.
  • Hong Kong, a former British colony, was returned to Chinese rule in 1997 on the promise that it would be accorded a high degree of autonomy for 50 years. But “Beijing’s full grip on power in Hong Kong may happen well before 2047,” said Diana Fu, an associate professor of political science at the University of Toronto.
  • The government promised economic growth of “over 6 percent,” a relatively modest target by the standards of China’s pre-pandemic expansion but a big turnabout from last year and a signal of its commitment to keeping the world’s second-largest economy humming.
  • The forecast indicates that China expects a strong rebound after the pandemic brought the country’s economy to a standstill for several months last year.
  • The spending increases over the past two decades, which have given China the world’s second-largest military budget today, have paid for a modernization and expansion program aimed at challenging American military dominance in the Pacific, especially in the South China Sea and around Taiwan.
  • Strengthening that message will be a major focus for Mr. Xi as he looks ahead to two important political events. In July, the party will celebrate the centenary of its founding.
  • As China’s rivalry over science and technology with the United States and other countries remains at a boil, Beijing is digging deep into its pockets in a bid for victory.
  • Just over a year after the coronavirus first emerged in the central Chinese city of Wuhan, Beijing also pledged to increase resources to guard against emerging infectious diseases and biosafety risks.
  • The Communist Party’s latest five-year plan specifically calls for the construction of a “Polar Silk Road,” presumably aimed at helping China better capitalize on new energy sources and faster shipping routes in the Arctic.
  • China’s military budget is set to rise by around 6.9 percent this year, a slight increase from last year. As overall government spending is projected to decline slightly, the People’s Liberation Army is still being funded robustly.
  • As countries continue to grapple with the pandemic, the party has doubled down on the message that China’s political model of strong, centralized leadership is superior to the chaos of liberal democracies.
  • The government addressed concerns about China’s aging population and shrinking labor force by announcing pension reforms and gradual changes to the official retirement age
  • On Friday, the government announced plans to build a system to support “family development” and strengthen marriage and family counseling services.
  • “Fully implement the party’s basic policy on religious work,” read a draft of the five-year plan. “Continue to pursue the sinicization of China’s religions and actively guide religions so that they can be compatible with socialist society.”
Javier E

Scientists Predicted the Coronavirus Pandemic - The Atlantic - 0 views

  • The now-prophetic words could be found at the end of a research paper published in the journal Clinical Microbiology Reviews in October of 2007: “The presence of a large reservoir of SARS-CoV-like viruses in horseshoe bats, together with the culture of eating exotic mammals in southern China, is a time bomb.”
  • The warning—made nearly 13 years ago and more than four years after the worrying first wave of severe acute respiratory syndrome, or SARS, killed nearly 800 people globally—was among the earliest to predict the emergence of something like SARS-CoV-2, the virus behind the current COVID-19 pandemic.
  • ilar.”
  • ...25 more annotations...
  • Dogged by skepticism and inconsistent funding, these coronavirus researchers were stymied from developing treatments and vaccines for SARS—many of which could have been helpful in the current crisis.
  • Another similarly affected researcher was Brenda Hogue, a virologist at Arizona State University in Tempe. Hogue had devoted her career to studying coronaviruses, focusing on the protein machinery that drives their assembly. After SARS, she and her colleagues turned part of their attention toward developing a vaccine. But when the funding dropped off in 2008, she said, the vaccine went into limbo “and we put our efforts into other directions.”
  • to some experts whose business it is to hunt potential pathogens before they spill over into human populations, the many years spent not girding for a serious coronavirus outbreak were tragically—and unnecessarily—wasted.
  • “We were out there on the ground after SARS, working on coronaviruses with Chinese colleagues in collaboration,” said Peter Daszak, president of the EcoHealth Alliance, a New York–based nonprofit group that took part in a large federally funded effort, called Predict, to hunt for new pandemic viruses in wildlife in 31 countries, including China. That program was famously defunded last fall, just before the SARS-CoV-2 outbreak began.
  • “But we were the only group of western scientists,” Daszak added. “How can we be the only people looking for these viruses when there was such a clear and present danger?”
  • when SARS emerged in late 2002, there was initially “general disbelief among medical people that a coronavirus could be the basis of such a huge outbreak.”
  • As that epidemic spread, an influx of new researchers crowded the field. More grants were awarded, and funding started to climb. “Everyone wanted to know where the virus had come from,” said Ralph Baric, a microbiologist at the University of North Carolina’s Gillings School of Global Public Health. Initial findings pointed to wild civets and raccoon dogs sold for meat and pelts, respectively, in Chinese markets. Later evidence began to implicate horseshoe bats as the original source of the infections. Some researchers whose pre-SARS careers had been grounded in basic coronavirus biology began working on therapies and vaccines—and they made steady progress for several years.
  • funding declines hobbled individual investigators who weren’t part of these larger consortia. Pharmaceutical companies that develop vaccines and therapies scaled back on coronavirus research, too. Within a few years after the SARS outbreak, public health funding agencies both in the United States and abroad “no longer regarded coronaviruses as a high public health threat compared to other diseases,” Saif wrote in an email.
  • Then on May 12, The Wall Street Journal reported that the Chinese government was responding in kind, “by stalling international efforts to find the source of the [SARS-CoV-2] virus amid an escalating U.S. push to blame China for the pandemic.”
  • To demonstrate that a particular virus is actually harmful to people, scientists need to isolate and culture the microbe and show it infects human cells in the lab
  • Led by virologist Zheng-Li Shi, the Wuhan team reported in 2013 that this particular virus, called WIV1, binds with ACE2 in civet and human cells, and then replicates efficiently inside them. “That was the red flag,” Saif said. Earlier evidence suggested that direct contact with these bats could lead to viral spillover in humans. “Now there was proof of that.”
  • hen cases of those diseases fell off, public-health responders shifted to other viral emergencies such as Ebola and Zika, and coronavirus research funding dropped sharply.
  • They created a hybrid microbe by attaching the spike protein from SHC014 to the genetic backbone of a SARS-like virus that was previously adapted to grow in mice. Called a chimera—an organism containing cells with more than one genotype—this lab-made microbe had no problem binding with ACE2 and infecting human cells. Baric’s research team concluded that like WIV1, any SARS-like viruses outfitted with the SHC014 spike could pose cross-species threats to people.
  • Baric acknowledged the risky nature of the research but emphasized the safety protocols. “In general, we don’t know the transmissibility or virulence potential of any bat viruses or chimeras,” Baric said in an email message. “Hence it’s best to keep and work with them under biosafety level 3 laboratory conditions to maximize safety.”
  • Baric also pointed out that a chimera would display a genetic signature “that says what it is.” The adjoining parts of a chimera segregate discreetly in a logical pattern.
  • A genetic analysis of the chimera produced in his lab, for instance, “would come out to be mouse-adapted SARS everywhere but the spike, which is SHC014.” Similar logical patterns are absent in SARS-CoV-2, indicating that the virus that causes COVID-19 evolved naturally.
  • ven as Baric and others were generating lab evidence that more SARS-like viruses were poised for human emergence, another outbreak—in pigs, not people—provided another strong and recent signal: Some 25,000 piglets were killed by a coronavirus in the Guangdong province of China, starting in 2016. That virus, too, was found in horseshoe bats, and Buchmeier described the outbreak as both a major cross-species spillover and a warning shot that was never really picked up by the broader public-health community.
  • The EcoHealth Alliance, which had been part of the Predict effort, maintained its own collaboration with the Wuhan Institute of Virology using funds supplied by the National Institutes of Health. But on April 24, the Trump administration—which is investigating whether SARS-CoV-2 escaped accidentally from the Wuhan Institute, an allegation that’s been broadly discredited—directed the NIH to cut off that support.
  • The bats had been trapped in a cave in Kunming, the capital of the Yunnan province. At least seven other SARS-like strains were present in that same colony, leading the researchers to speculate that bat coronaviruses remained “a substantial global threat to public health.”
  • To disease experts, the bickering is a worrying—perhaps even astonishing—indicator that at least some global leaders still aren’t hearing what they have to say about the threat of coronaviruses, and Baric asserted that the ongoing pandemic exposes the need for better communication between countries, not less. “That is absolutely key,” he said. “Critical information needs to be passed as quickly as possible.”
  • Many other warnings would follow.Indeed, evidence of a looming and more deadly coronavirus pandemic had been building for years. Yet experts who specialize in coronaviruses—a large family of pathogens, found especially in birds and mammals, that can cross over to humans from other mammals and cause varying degrees of illness—struggled to convince a broader audience of the risk
  • the number of coronavirus-research grants funded by the National Institutes of Health—which had increased from a low of 28 in 2002 to a peak of 103 in 2008—went into a tailspin.
  • Though support for coronavirus research spiked a bit with the MERS outbreak in 2012, the increase was short-lived. Since that outbreak was quickly contained, the disease didn’t raise wider concerns and grant opportunities declined further.
  • Ironically, just as funding for drugs and vaccines was drying up, evidence that other coronavirus threats lurked in wildlife was only getting stronger
  • Ten years would pass, however, before researchers could show there were other SARS-like viruses in nature that also bind with ACE2. The evidence came from a team based at the Wuhan Institute of Virology
1 - 4 of 4
Showing 20 items per page